Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers Academic Article uri icon

Overview

MeSH Major

  • Annexin A2
  • Antigens, CD
  • Cadherins
  • Lung
  • Microvessels
  • Protein Tyrosine Phosphatases

abstract

  • CW002 has predictable pharmacokinetics and is likely to have a rapid onset with an intermediate duration of action at 3× ED95. This model provides information to inform critical decisions (e.g., dose, study design) for continued development of CW002.

publication date

  • June 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5953789

Digital Object Identifier (DOI)

  • 10.1097/ALN.0000000000002157

PubMed ID

  • 29494403

Additional Document Info

start page

  • 1107

end page

  • 1116

volume

  • 128

number

  • 6